U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Information on Mycophenolate
  1. Postmarket Drug Safety Information for Patients and Providers

Information on Mycophenolate

The drug mycophenolate is in a class of medications called immunosuppressive agents. It works by weakening the body's immune system so it will not attack and reject a transplanted organ.

The list of mycophenolate-containing medicines includes CellCept (mycophenolate mofetil), Myfortic (mycophenolic acid), and any generic mycophenolate mofetil or mycophenolic acid products.

Related Information

Regulatory History and Labeling from Drugs@FDA

Back to Top